These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17365452)

  • 1. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
    Imai A; Furui T
    J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
    Blumenfeld Z; von Wolff M
    Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
    Sugiyama M; Imai A; Takahashi S; Hirano S; Furui T; Tamaya T
    Int J Oncol; 2003 Aug; 23(2):445-52. PubMed ID: 12851694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are gonadotropin-releasing hormone analogs safe and effective for protection of ovarian reserve against chemotherapeutic insult?
    Sönmezer M; Taşçi T; Gözüküçük M
    Gynecol Endocrinol; 2008 Feb; 24(2):64-5; author reply 66. PubMed ID: 18210327
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
    Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
    Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do GnRH analogs protect against ovarian toxicity of chemotherapy?
    Moore HC
    Breast Cancer Res Treat; 2009 Oct; 117(3):569-70. PubMed ID: 19234783
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
    Imai A; Sugiyama M; Furui T; Tamaya T; Ohno T
    Gynecol Obstet Invest; 2007; 63(2):102-6. PubMed ID: 17028438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
    Peccatori F; Demeestere I
    Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of gonadal damage during cytotoxic therapy.
    Blumenfeld Z; Haim N
    Ann Med; 1997 Jun; 29(3):199-206. PubMed ID: 9240625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
    Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
    Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced gonadotoxicity.
    Wang PH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):1-2. PubMed ID: 20466285
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model.
    Tan SJ; Yeh YC; Shang WJ; Wu GJ; Liu JY; Chen CH
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):182-5. PubMed ID: 20074846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
    Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
    Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data.
    Beck-Fruchter R; Weiss A; Shalev E
    Hum Reprod Update; 2008; 14(6):553-61. PubMed ID: 18820006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on the letter "Fertility preservation and GnRHa for chemotherapy: debate".
    von Wolff M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; Nitzschke M
    Arch Gynecol Obstet; 2010 Dec; 282(6):717-8. PubMed ID: 20428880
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
    Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
    Sinha R; Dionne JM
    Arch Dis Child; 2008 May; 93(5):444-5. PubMed ID: 17908713
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
    Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
    Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.